The European dietary supplement market was valued at over €26 billion in 2024, growing at roughly 8–9% per year. Germany accounts for the largest single national share [1]. Spending is especially accelerating fastest among adults aged 25–45. Precisely the biohacker-adjacent cohort most likely to be running a larger multi-supplement stack.
Here is the question very few of us who consume supplements ask: Is any of it actually reaching the target?
Not "is vitamin D important?" It is. Not "does magnesium matter?" It does. The question is whether the specific form you bought, taken at the time you take it, with the other things you take it with, is actually being absorbed and used by your body.
The answer, across a surprisingly large number of common supplement combinations, is: probably less than you think. Sometimes much less. Occasionally, not at all.
This is not a fringe concern. It is a well-documented pharmacological phenomenon called bioavailability, and the supplement industry's incentive structure means it rarely makes the label.
If you're spending €30–60 or even more a month on supplements without knowing your baseline levels, you're optimising blind. Aniva tests 140+ biomarkers: including vitamin D; magnesium; ferritin; zinc; omega-3 index; and more. So you can supplement with precision instead of guesswork. Join the free waitlist →
Bioavailability is the fraction of an ingested substance that successfully enters circulation and reaches the site of action in a biologically active form. [2] It sounds like an abstract pharmacology concept. It has very practical implications for your supplement spend.
Think of it this way. If you take 400mg of magnesium oxide, the form found in most budget supplements, and your body absorbs roughly 4% of it, you've delivered about 16mg of usable magnesium. The rest exits through your digestive system, often with some urgency, which is why magnesium oxide is also sold as a laxative. If you take 200mg of magnesium glycinate and absorb roughly 80% of it, you've delivered 160mg of usable magnesium at half the elemental dose.
Same mineral. Vastly different outcome. And that gap is not a marketing claim. It's measurable in blood.
A study testing 15 commercially available magnesium supplements found an extraordinarily wide range of absorption profiles across different formulations. [3] One supplement raised serum magnesium levels measurably within two hours of ingestion. Another, taken at the same dose, produced no significant change at any time point measured over six hours. Both were sold as "magnesium supplements."
The bioavailability problem operates across multiple dimensions simultaneously: the form of the nutrient, the other substances present in your gut at the same time, the health of your digestive system, and the specific interactions between the nutrients you're stacking. Understanding all four is what separates a useful supplement protocol from an expensive habit.
Every mineral and many vitamins come in multiple chemical forms, with substantially different absorption profiles. This is not a minor technical distinction, it is often the difference between a supplement working and not working.
Magnesium glycinate and magnesium malate are among the most bioavailable forms; magnesium oxide is among the least. [3] Calcium citrate is more bioavailable than calcium carbonate, particularly when taken without food. [4] Methylfolate is more readily utilised than folic acid, especially for the 10–15% of Europeans carrying MTHFR polymorphisms that impair folic acid conversion. Calcifediol (25-OH vitamin D) is more bioavailable than the cholecalciferol (D3) form in several populations. [2]
The practical implication: if you've been taking a supplement for months without noticing any effect, check the form before concluding the nutrient "doesn't work for you." The nutrient may be sound. The formulation may not be.
Your gut microbiome is not a passive bystander in nutrient absorption. Research into the so-called "micronutrient-microbiome axis" has found that commensal bacterial species both consume nutrients in the gut and produce them, and their overall composition substantially affects how much of a given supplement makes it into your bloodstream. [2] Certain Bifidobacterium and Lactobacillus strains synthesise B vitamins and vitamin K; others compete with the host for minerals.
This means two people taking the identical supplement stack can experience meaningfully different outcomes depending on their gut composition. It also means chronic antibiotic use, inflammatory gut conditions, or simply an unvaried diet can undermine absorption in ways that are invisible unless you test the downstream biomarkers.
This is where things get expensive. Not because supplements are wasted by poor formulation alone, but because common stacking patterns actively interfere with each other's absorption at a mechanistic level. The supplement industry's incentive is to sell you more products. Nobody profits from telling you that two of them are competing for the same transporter.
Calcium and non-haem iron use overlapping transport mechanisms in the intestinal wall. When both are present in significant quantities at the same time, they compete directly for absorption and calcium, taken in supplement doses, consistently suppresses iron uptake. [2]
The practical consequence: if you're taking a calcium supplement with breakfast and also trying to address low ferritin with an iron supplement, you may be significantly undermining the iron. The standard clinical advice is to separate them by at least two hours. The standard supplement stack doesn't come with that instruction.
This interaction is particularly relevant for women who are supplementing both calcium (for bone health) and iron (for fatigue and hair loss) simultaneously. Ferritin deficiency is already the most under-diagnosed nutritional problem in Europe. See our article on ferritin and iron status → Taking calcium with your iron supplement may be turning a correctible problem into a persistent one.
Zinc and copper share intestinal absorption pathways via metallothionein proteins. High-dose zinc supplementation — common in immunity and testosterone-support stacks — reduces copper absorption. [2] Copper deficiency, in turn, impairs iron metabolism, red blood cell formation, and connective tissue synthesis.
Chronic zinc supplementation above 25–40mg per day without copper co-supplementation has been associated with iatrogenic copper deficiency in clinical settings. Most zinc supplements are sold at 25–50mg doses. Most do not mention copper on the label.
The interaction runs in the other direction too: high-dose copper supplementation can suppress zinc. This is why clinical guidance consistently recommends testing both before supplementing either in therapeutic doses, and maintaining roughly a 10:1 zinc-to-copper ratio if supplementing long-term.
Vitamin D is arguably the most robustly evidence-supported supplement for Europeans living above the 50th parallel. See our full guide to vitamin D in Northern Europe → But supplementing D3 in isolation misses two critical cofactors that determine whether the vitamin actually does what you're hoping it will.
Vitamin D raises circulating calcium levels. Vitamin K2 is responsible for directing that calcium to bones and teeth rather than arterial walls. Without sufficient K2, long-term high-dose vitamin D supplementation may drive calcium into vasculature, a concern supported by mechanistic evidence, though long-term RCT data in humans remains limited.
Magnesium is equally critical. Roughly 70–80% of enzymatic reactions involving vitamin D require magnesium as a cofactor. [2] A person who is magnesium deficient, a common state across Europe, given that intensive farming has depleted soil magnesium content, may see minimal response to vitamin D supplementation regardless of dose, because the conversion and utilisation machinery requires magnesium to function.
The result: the most common vitamin D supplementation pattern (D3 alone, often without food) is also the least complete. D3 + K2 + magnesium, taken with a fat-containing meal, is a meaningfully different intervention.
Vitamins A, D, E, and K are fat-soluble. They require emulsification by bile acids — a process triggered by dietary fat in the meal — to be packaged into chylomicrons and absorbed through the intestinal wall. [5] Taking fat-soluble vitamins on an empty stomach, or with a low-fat meal, substantially reduces their bioavailability.
One study found that beta-carotene absorption from supplements was significantly lower when taken without fat, because the emulsification required for chylomicron packaging did not occur adequately. [5] The same mechanism applies to D3, K2, and vitamin A supplements. The difference is not trivial — it is the difference between the supplement working or not.
If you take your vitamin D at the same time each morning with black coffee and nothing else, you may be absorbing a fraction of what the label suggests.
There is a deeper issue beneath the absorption and interaction questions, and it is one the supplement industry is structurally incentivised to obscure: most people have no idea whether they actually need what they're taking.
Vitamin D deficiency is genuinely prevalent in Northern Europe — the Robert Koch Institut's DEGS data puts roughly 56% of German adults below 50 nmol/L, particularly in winter. See our full article on vitamin D → Magnesium deficiency is common, particularly among people with high stress loads and poor dietary variety. Iron deficiency without anaemia affects an estimated 15–30% of European women of reproductive age.
But supplementing these nutrients without knowing your baseline is not the same as addressing a deficiency. It is a guess. And that guess has a meaningful failure mode in both directions: you may be supplementing a nutrient you are already sufficient in, wasting money and potentially pushing into excess, or you may be supplementing the wrong thing entirely while the actual deficiency goes unaddressed.
Vitamin D toxicity — hypervitaminosis D — is a real, documented clinical entity caused by over-supplementation. Excess iron causes oxidative stress and organ damage. Excess selenium, common in some anti-aging stacks, can cause selenosis. These are dose-dependent consequences of supplementing without a baseline.
The correction is straightforward: test before you supplement, and test again after. Not once, but periodically, to track whether your levels are moving in the right direction and whether you've reached sufficiency.
Aniva's annual panel tests 140+ biomarkers including vitamin D (25-OH), magnesium, ferritin, zinc, copper, omega-3 index, and B12 — the full picture of what your supplement stack is actually achieving. ISO 15189-certified German laboratory, €199/year. See the full biomarker list →
The European Food Safety Authority (EFSA) maintains a public register of health claims submitted by supplement manufacturers for regulatory approval. The data is instructive. The vast majority of submitted claims for dietary supplements have been rejected due to insufficient or inconclusive evidence. This is not a condemnation of every supplement on the market. Some nutrients have robust evidence bases — vitamin D, omega-3, folic acid in pregnancy, iodine in iodine-deficient populations. But it is a calibration tool for how to read supplement marketing.
When a product claims to "support energy," "promote immunity," or "optimise performance," those phrases exist precisely because the evidentiary bar for a specific, substantiated health claim could not be cleared. The supplements with genuine evidence are genuinely useful, when indicated. The supplements riding on the back of those nutrients' reputations, via mechanisms that have not been validated in humans, are a different category entirely.
The point of this article is not that supplements are useless. It is that most supplement spending is poorly targeted, poorly timed, and poorly formulated. The contrast with the small number of nutrients that meet a high evidentiary standard is instructive.
Vitamin D has genuinely strong evidence for its role in immune function, bone metabolism, mood regulation, and cardiovascular health — but in populations that are deficient. The key phrase is "when deficient." Studies on vitamin D supplementation in populations with adequate baseline levels consistently show attenuated or absent effects. The benefit is in correcting deficiency, not in pushing adequate levels higher. Testing to establish your baseline, supplementing to reach the 75–100 nmol/L functional range, and retesting to confirm you have done so, is a qualitatively different approach than taking 1,000 IU daily because everyone else does.
Magnesium is involved in over 300 enzymatic reactions, including virtually all energy metabolism pathways. European dietary surveys consistently show inadequate magnesium intake, driven by reduced soil content from intensive agriculture and a processed-food-heavy diet. Magnesium glycinate and malate are among the most bioavailable forms with the lowest likelihood of gastrointestinal side effects. But the dose required to correct deficiency varies substantially by individual — another reason testing is more useful than generic dosing recommendations.
The Omega-3 Index — EPA and DHA as a percentage of total red blood cell fatty acids — is one of the most clinically validated cardiovascular risk markers most people have never heard of. An Omega-3 Index below 4% carries cardiovascular risk comparable to smoking. Above 8% is considered cardioprotective. The average European is substantially below 8%. But supplementing omega-3 without measuring your index is again a guess: you don't know whether you're at 3% (correction urgent) or 7% (correction modest), and therefore don't know what dose is required or whether you've achieved the target.
These three supplements share a common logic: the evidence for their benefit is contingent on addressing a deficiency that is prevalent in the European population — but not universal. Testing tells you whether you are in the group that benefits, and at what dose.
The framework is straightforward, even if it requires more effort than opening a browser tab and ordering a subscription stack.
Step one: test your baseline. Before any supplementation decisions, establish where your key biomarkers actually sit. At minimum: vitamin D, magnesium, ferritin and iron status, zinc and copper, omega-3 index, B12 and folate, and if you're running an immune or cardiovascular stack, hs-CRP, and a full lipid panel including ApoB.
Step two: identify genuine deficiencies. Not "low-normal" by reference-range standards, but below the functional optima that current evidence links to health outcomes. Ferritin below 50 µg/L, vitamin D below 75 nmol/L, omega-3 index below 8%, magnesium in the lower quartile, these are the targets that matter.
Step three: address them with the right form. Magnesium glycinate, not oxide. Vitamin D3 with K2, taken with food containing fat. Iron with vitamin C, away from calcium. Not because the label is wrong, but because the biochemistry demands it.
Step four: retest after 12–16 weeks. This is the step most people skip and the one that transforms supplementation from guesswork into a feedback loop. Did your vitamin D reach 80 nmol/L? Did your ferritin improve? If not, was it dose? Formulation? Absorption? A concurrent interaction? You cannot answer these questions without data.
The biohacking community has internalised a sophisticated understanding of training variables, sleep metrics, and glucose response. The same rigour applied to the supplement cabinet — measure, intervene, remeasure — transforms €40/month from an optimistic bet into an evidence-based investment.
Aniva tests 140+ biomarkers annually, including the full nutritional panel your supplement decisions should be based on. ISO 15189-certified German laboratory, plain-language results, personalised action plan. €199/year — less than five months of the average European supplement spend. Join the free waitlist →
The supplement industry is not a scam. Several of the most common supplements have robust evidence bases and are genuinely useful for the large fraction of Northern Europeans with documented deficiencies. But the industry's incentive structure rewards selling volume, not optimising outcomes — and the result is a market saturated with poor formulations, incomplete stacks, and products targeting people who don't need them.
The absorption research makes several things clear: form matters enormously; timing matters; combinations matter; and individual baseline levels matter most of all. A stack designed around a generic protocol, ten products chosen from a podcast recommendation, is not a personalised health intervention. It is a guess dressed up in amber bottles.
Test. Target. Retest. That is what a supplement protocol built on evidence looks like, not more products, but better-directed ones.
Further Reading from Aniva:
This content is for informational purposes only and is not medical advice. Supplement dosing and interactions are highly individual. Always discuss supplementation decisions with a qualified healthcare professional before making changes, particularly if you take prescription medications or have underlying health conditions.
